4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: January 15, 2019
Period of Report: January 14, 2019
Accession Number: 0001645470-19-000003

View Document ↗ View on SEC.gov ↗